CPRX
CATALYST PHARMACEUTICALS, INC.
Key Financials
Operating Income
$257.8M
↑ 32.1%
Revenue
$589.0M
↑ 19.8%
Shareholders' Equity
$954.3M
↑ 31.1%
Total Liabilities
$149.7M
↑ 21.0%
Net Income
$214.3M
↑ 30.8%
Cash & Equivalents
$709.2M
↑ 37.0%
EPS (Diluted)
$1.68
↑ 28.2%
Total Assets
$1.1B
↑ 29.7%
Recent SEC Filings
| Form Type | Filed Date | Link |
|---|---|---|
| DEFA14A | 6/30/2026 | View on SEC |
| 8-K | 6/30/2026 | View on SEC |
| 8-K | 6/23/2026 | View on SEC |
| DEFM14A | 6/8/2026 | View on SEC |
| 4 | 6/5/2026 | View on SEC |
| PREM14A | 5/28/2026 | View on SEC |
| DEFA14A | 5/12/2026 | View on SEC |
| 8-K | 5/11/2026 | View on SEC |
| 10-Q | 5/11/2026 | View on SEC |
| DEFA14A | 5/8/2026 | View on SEC |
Company Information
| Field | Value |
|---|---|
| Ticker | CPRX |
| Company Name | CATALYST PHARMACEUTICALS, INC. |
| CIK | 1369568 |
| Sector | Pharmaceutical Preparations |
| Industry | Large accelerated filer |
| Exchange | Nasdaq |
| SIC Code | 2834 |
| SIC Description | Pharmaceutical Preparations |
| Entity Type | operating |
| Fiscal Year End | 1231 |
| State of Incorporation | DE |
| Phone | (305) 529-2522 |